Bioequivalence and Bioavailability Forum • ANVISA guidelines for two-stage design

ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by Mauricio Sampaio – Brazil, 2020-02-12 18:11 (1533 d 20:56 ago) – Posting: # 21167
Views: 6,294

Hi El Maestro

❝ Ermmm...... WHAT???? :-D :party:

Sorry! Change to: unknowledgement of intra-individual variability.

Now, any comments or contribution?

Complete thread:

ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-11 20:52
- Brainless copy-and-paste-devil Helmut 2020-02-12 02:26
  - Brainless copy-and-paste-devil Mauricio Sampaio 2020-02-12 17:33
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 08:27
  - ANVISA guidelines for two-stage design nobody 2020-02-12 08:49
  - ANVISA guidelines for two-stage design Helmut 2020-02-12 13:12
  - ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-12 17:04
  - ANVISA guidelines for two-stage designMauricio Sampaio 2020-02-12 17:11
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 21:54
  - crap Helmut 2020-02-15 17:53
    - crap Mauricio Sampaio 2020-02-16 05:01
      - crap Helmut 2020-02-16 15:43
        
        crap d_labes 2020-02-16 19:34
        
        Explained crap remains crap Helmut 2020-02-17 12:49
        
        Proposed changes Mauricio Sampaio 2020-02-17 13:50
        
        Proposed changes Helmut 2020-02-17 14:16

Admin contact
22,993 posts in 4,828 threads, 1,653 registered users;
103 visitors (0 registered, 103 guests [including 3 identified bots]).
Forum time: 16:07 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means. Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz